Vieira JL, Pfeffer M, Claggett BL, et al. - Researchers undertook this single centre, retrospective, observational cohort analysis to determine the link between the use of statin therapy and subsequent development of neurological events, especially stroke, after continuous-flow left ventricular assist systems (CF-LVAS) implantation. The study sample comprised 200 consecutive adults implanted with a durable CF-LVAS. Findings revealed lower rates of neurological events in correlation with statin prescription after CF-LVAS, driven mainly by a decrease in ischemic strokes. According to these findings, the use of statins after CF-LVAS may be continued in most patients with a pre-existing indication for statin therapy, in an attempt to reduce the incidence of ischemic stroke.